Amarin Corp Plc (AMRN)

[antibluechip]

Dukes,
A few questions about the case of FHEP not covering Vascepa. Is FHEP liable if one of their patients on gV has a cardiac event? Could FHEP avoid liability by saying that gV was equivalent to V? Wouldn't the FDA CVD Indication for V supercede any "equivalence" argument by FHEP? Wouldn't the "liability issue" be a better point of attack than the "infringement issue?" Dave